发明名称 |
Endogenous retrovirus up-regulated in prostate cancer |
摘要 |
A specific member of the HERV-K family located in chromosome 22 at 20.428 megabases (22q11.2) has been found to be preferentially and significantly up-regulated in prostate tumors. The invention provides methods for diagnosing prostate cancer, comprising the step of detecting in a patient sample the presence or absence of an expression product of the virus. The virus has five features not seen in other HERV-K members: (1) its own specific nucleotide sequence, and consequently amino acid sequences; (2) tandem 5'LTRs; (3) a fragmented 3'LTR; (4) an env gene interrupted by an alu insertion; and (5) unique gag sequences.
|
申请公布号 |
EP2208736(A2) |
申请公布日期 |
2010.07.21 |
申请号 |
EP20100153737 |
申请日期 |
2002.12.09 |
申请人 |
NOVARTIS VACCINES AND DIAGNOSTICS, INC. |
发明人 |
HARDY, STEPHEN F.;GARCIA, PABLO;WILLIAMS, LEWIS T.;ESCOBEDO, JAIME |
分类号 |
C07K14/47;A61K31/7088;A61K38/16;A61K39/00;A61K39/21;A61K39/395;A61K48/00;A61P31/14;C07H21/00;C07K14/15;C07K16/10;C12N1/00;C12N7/00;C12N15/48;C12Q1/68;C12Q1/70;G01N33/574 |
主分类号 |
C07K14/47 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|